Legacy Wealth Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Legacy Wealth Asset Management's BIIB Position: Q3 2025 in Review
Legacy Wealth Asset Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 2,511 shares — an estimated $315K sold.
Legacy Wealth Asset Management first reported a position in BIIB in Q4 2020 and held it in 19 quarters. The position peaked at $1.09M in Q3 2022. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Legacy Wealth Asset Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Legacy Wealth Asset Management sold 2,511 Biogen shares in Q3 2025, an estimated $315K.
- Legacy Wealth Asset Management first reported a position in Biogen in Q4 2020 and held it in 19 quarters.
- Legacy Wealth Asset Management's Biogen position peaked at $1.09M in Q3 2022.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Legacy Wealth Asset Management's 13F filing for Q3 2025, filed 14 Oct 2025.